- Home
- AGEN vs PRE Comparison
AGEN vs PRE Comparison
Compare AGEN & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- PRE
- Stock Information
- Founded
- AGEN 1994
- PRE 2014
- Country
- AGEN United States
- PRE Hong Kong
- Employees
- AGEN N/A
- PRE N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- AGEN Health Care
- PRE Industrials
- Exchange
- AGEN Nasdaq
- PRE Nasdaq
- Market Cap
- AGEN 87.7M
- PRE 105.1M
- IPO Year
- AGEN 2000
- PRE N/A
- Fundamental
- Price
- AGEN $5.29
- PRE $7.98
- Analyst Decision
- AGEN Strong Buy
- PRE Buy
- Analyst Count
- AGEN 3
- PRE 1
- Target Price
- AGEN $16.33
- PRE $9.00
- AVG Volume (30 Days)
- AGEN 1.2M
- PRE 47.1K
- Earning Date
- AGEN 08-11-2025
- PRE 08-12-2025
- Dividend Yield
- AGEN N/A
- PRE N/A
- EPS Growth
- AGEN N/A
- PRE N/A
- EPS
- AGEN N/A
- PRE N/A
- Revenue
- AGEN $99,524,000.00
- PRE $41,520,000.00
- Revenue This Year
- AGEN $25.31
- PRE $198.17
- Revenue Next Year
- AGEN N/A
- PRE $59.73
- P/E Ratio
- AGEN N/A
- PRE N/A
- Revenue Growth
- AGEN N/A
- PRE 78.72
- 52 Week Low
- AGEN $1.38
- PRE $3.10
- 52 Week High
- AGEN $7.34
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- AGEN 44.92
- PRE 48.84
- Support Level
- AGEN $5.34
- PRE $7.38
- Resistance Level
- AGEN $6.58
- PRE $8.36
- Average True Range (ATR)
- AGEN 0.44
- PRE 0.45
- MACD
- AGEN -0.16
- PRE -0.04
- Stochastic Oscillator
- AGEN 10.69
- PRE 42.25
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.